Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07449091 · ClinicalTrials.gov registry record
Adaptability of an Undetectable = Untransmissible Model for HBV
A clinical trial, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- 55
- Enrollment target
NCT07449091 is a clinical trial that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 55 participants.
The verdict
NCT07449091 is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- 55 participants
- Enrollment target
Study Summary
Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fear of transmission to their partners leading to social isolation and impact on their personal lives. This study will provide data correlating serum and body fluid viral levels in persons with chronic hepatitis B infection not on therapy and those with viral suppression on long-term anti-retroviral therapy (ART) that may support the concept of "Undetectable=Untransmissible" (U=U) in patients with chronic hepatitis B.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2027-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07449091
The ClinicalTrials.gov registry entry for NCT07449091 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07449091 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07449091 about?
NCT07449091 is a clinical study titled "Adaptability of an Undetectable = Untransmissible Model for HBV". Persons with chronic hepatitis B (HBV) infection and active viremia are infectious and may transmit virus to others through blood/body fluid exposure. Immune tolerant treatment naive persons with hepatitis B infection express anxiety regarding disclosure of their infection status and significant fea...
What is the current status of trial NCT07449091?
This trial is currently recruiting. The enrollment target is 55 participants. The study started on 2026-05-01. Estimated completion is 2027-09.
Who is sponsoring clinical trial NCT07449091?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.